Faculty profile

Alan So

ResearcherUrologic SciencesUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Alan So

Researcher

Urologic Sciences

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
13 publications in the last five years, latest in 2026.
Principal investigator on 3 research grants (3 CIHR), most recently in 2018.
Supervised 1 trainee who won CIHR awards, most recently in 2011.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

515

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bladder Cancer Organ Decellularization Tissue Engineering Yb-1 Chemotherapy Clinical Trial Intravesical Therapy Nanoparticles

Latest papers

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.
Endocrine oncology (Bristol, England) · 2026
Reply by Authors.
The Journal of urology · 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.
The Journal of urology · 2025

All 79 publications

Latest funding

YB-1 in the development of sunitinib-resistance in metastatic clear cell renal cell carcinoma.
CIHR · 2018 · Nominated PI
$60,000
Novel 3D personalized bladder cancer model on demand: A new era for personalized medicine.
CIHR · 2018 · Nominated PI
$248,625
Optimizing the Curative Treatment for High Risk Prostate Cancer: Combining Advanced Imaging, Trans-perineal Mapping Biopsies, and Dual Air Kerma Strength LDR Brachytherapy Implants to Minimize Radiation Dose to Normal Tissues
CIHR · 2016 · Co-investigator
$1,113,078

All 9 grants and awards

79 publications.

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Gorman M, Usmani N, Pollak MN, Ghosh S, Elangovan A, Kim J, Thoms J, Bouchard M, Peacock M, Wang Y, Fleshner NE, Campbell H, Vigneault E, Vincent F, So A, Cury FL, Quon HC, Carlson RG, Lambert C, Klotz L, Chi K, Brundage M, Courneya KS, Eigl BJ

Endocrine oncology (Bristol, England)2026

DOI: 10.1530/eo-25-0114 PMID: 42395839

Reply by Authors.

Eigl BJ, Elangovan A, Ghosh S, Kim JO, Thoms J, Bouchard M, Peacock M, Fleshner N, Campbell H, Vigneault E, Vincent F, So A, Cury F, Quon H, Carlson R, Lambert C, Klotz L, Chi K, Brundage M, Pollak M, Rebane L, Chiu L, Courneya KS, Usmani N

The Journal of urology2025

DOI: 10.1097/ju.0000000000004731 PMID: 40928018

A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.

The Journal of urology2025

DOI: 10.1097/ju.0000000000004695 PMID: 40711960

Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.

Hu B, Alsyouf M, Farkouh A, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black PC, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Daneshmand S

The Journal of urology2025

DOI: 10.1097/ju.0000000000004561 PMID: 40203124

Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?

Soytas M, Dragomir A, Sawaya GB, Hesswani C, Tanguay M, Finelli A, Wood L, Rendon R, Bansal R, Lalani A

BJU International20255 citations

DOI: 10.1111/bju.16609

Evaluating different methods for kidney recellularization.

Luque-Badillo AC, Monjaras-Avila CU, Adomat H, So A, Chavez-Muñoz C

Scientific reports2024

DOI: 10.1038/s41598-024-74543-w PMID: 39384961

Impact of the COVID-19 Pandemic on Access to Cancer Surgery: Analysis of Surgical Wait Times in British Columbia, Canada.

Shojaei D, Bakos B, Loree J, Mah A, So A, McGahan C, Phang TP, Brown CJ

Disaster medicine and public health preparedness2023

DOI: 10.1017/dmp.2023.223 PMID: 38131186

Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population data.

Mohammadi T, Guh DP, Tam ACT, Pataky RE, Black PC, So A, Lynd LD, Zhang W, Conklin AI

Cancer medicine2023

DOI: 10.1002/cam4.6587 PMID: 37740609

Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.

Bhojani N, Bidair M, Kramolowsky E, Desai M, Doumanian L, Zorn KC, Elterman D, Kaufman RP, Eure G, Badlani G, Plante M, Uchio E, Gin G, Paterson R, So A, Roehrborn C, Motola J, Kaplan S, Humphreys M

The Journal of urology2023

DOI: 10.1097/ju.0000000000003483 PMID: 37115632

Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.

Daneshmand S, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black P, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Luo C, Li M, Hu B

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2023

DOI: 10.1200/jco.22.00624 PMID: 36913642

Something wrong or missing on this profile? Suggest a correction

Alan So

Research

Latest papers

Latest funding

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Reply by Authors.

A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.

Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.

Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?

Evaluating different methods for kidney recellularization.

Impact of the COVID-19 Pandemic on Access to Cancer Surgery: Analysis of Surgical Wait Times in British Columbia, Canada.

Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population data.

Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.

Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.

Frequent collaborators

Antonio Finelli

Martin Gleave

Wassim Kassouf

Dean Elterman

Bobby Shayegan

Neil Fleshner

Peter Black

Lucia Nappi

Eric Vigneault

Larry Goldenberg

Kim Chi

Nawaid Usmani

Philippe Violette

Libni Eapen

Anne-Marie Mes-Masson

Ilias Cagiannos

Girish Kulkarni

Michael Peacock

Michael Brundage

Aly-Khan Lalani

Rahul Bansal

Nicholas Power

Stephen Pautler

Gang Wang

Christina Canil

Michael Pollak

Luke Lavallée

Robert Siemens

Rodney Breau

Sebastien Hotte

Richard Sowery

David Huntsman

Carmen Loiselle

Anna Tinker

Julian Kim

Caigan Du

York Pei

Shabbir Alibhai

Victor Ling

Dawn Stacey